Description

Dysport 500 (Ipsen): High Diffusion and Ultra-Rapid Clinical Onset

Dysport 500 (abobotulinumtoxinA) is an original, premium European neuroprotein manufactured by the French pharmaceutical company Ipsen. The product possesses a unique clinical profile: due to the lower molecular weight of its complexing proteins, it exhibits a high degree of tissue diffusion and an exceptionally rapid onset of action. The 500-unit vial (measured in specific Speywood units, not equivalent to Botox units) is the most rational and cost-effective solution for large-scale procedures: hyperhidrosis therapy, platysmal band correction, and comprehensive rejuvenation of extensive areas (e.g., a broad forehead).

Key Benefits Dysport 500:

High Diffusion Capacity: Ensures a soft, even distribution of the toxin, allowing the practitioner to cover a larger muscle area with fewer injection points.

Ultra-Rapid Onset: Initial signs of muscle relaxation are frequently observed within 24 to 48 hours post-treatment.

Maximum Profitability: The 500U dosage optimizes protocols for hyperhidrosis treatment and extensive body/neck corrections.

Global Recognition: FDA and EMA approved, backed by decades of proven safety and efficacy in both aesthetic medicine and neurology.

Indications:

Comprehensive treatment of localized hyperhidrosis (axillae, palms, soles).

Correction of dynamic wrinkles over large areas (forehead, crow’s feet).

Smoothing of platysmal bands (Nefertiti neck lift).

Correction of masseter and trapezius muscle hypertonicity.

Specifications:

Active Ingredient: AbobotulinumtoxinA (500 Speywood Units).

Form: Lyophilized powder (1 vial).

Manufacturer: Ipsen Biopharm Ltd. (UK).